Schonfeld Strategic Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-60,074
| Closed | -$1.02M | – | 2042 |
|
|
2024
Q1 | $1.02M | Sell |
60,074
-80,926
| -57% | -$1.38M | 0.01% | 1053 |
|
|
2023
Q4 | $1.44M | Buy |
141,000
+19,200
| +16% | +$196K | 0.01% | 851 |
|
|
2023
Q3 | $1.1M | Buy |
121,800
+16,700
| +16% | +$151K | 0.01% | 872 |
|
|
2023
Q2 | $1.13M | Buy |
105,100
+70,700
| +206% | +$761K | 0.01% | 922 |
|
|
2023
Q1 | $352K | Buy |
34,400
+400
| +1% | +$4.09K | ﹤0.01% | 1281 |
|
|
2022
Q4 | $359K | Buy |
+34,000
| New | +$359K | ﹤0.01% | 1690 |
|
|
2021
Q4 | – | Sell |
-35,858
| Closed | -$809K | – | 2012 |
|
|
2021
Q3 | $809K | Buy |
+35,858
| New | +$809K | 0.01% | 972 |
|
|
2021
Q2 | – | Sell |
-48,373
| Closed | -$2.02M | – | 1936 |
|
|
2021
Q1 | $2.02M | Buy |
+48,373
| New | +$2.02M | 0.02% | 626 |
|